Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Grow meth' OR with Authors including 'Grow meth' OR with Abstract including 'Grow meth' OR with Keywords including 'Grow meth'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Quadri SK, Clark JL, Meit... Effects of LSD, Pargyline and Haloperidol on Mammary Tumor Growth in R... Proc.Soc.Exp.Biol.Me... 1973
Turek IS, Soskin RA, Kurl... Methylenedioxyamphetamine (MDA) Subjective Effects Journal of Psychedel... 1974
Goodrich CA, Hoff KM, Bak... The Maturational Effects of LSD upon Brain Weight and Behavior in the ... Comp Gen Pharmacol 1974
Quadri SK Effects Of Central Acting Drugs And Ergot Derivatives On Prolactin And... Assertation Abst. In... 1974
Quadri SK Effects of Central Acting Drugs and Ergot Derivatives on Prolactin and... Dissertation Abstr.I... 1974
Baker PC, Hoff KM The effects of LSD upon brain indoleamine maturation in the brain of t... Gen Pharmacol 1975
Pollock, S.H. Book Review: Growing Wild Mushrooms by B. Harris Journal of Psychoact... 1976
Poffenbarger M, Fuller GM Effects of Psychotropic Drugs on Neurotubule Assembly J.Neurochem. 1977
Demisch L, Neubauer M Stimulation of human prolactin secretion by mescaline Psychopharmacology (... 1979
Young RE, Milroy R, Hutch... The Rising Price Of Mushrooms The Lancet 1982
Montagne M Drug-taking paraphernalia J Psychoactive Drugs 1983
Wolfson PE Meetings at the edge with Adam: A man for all seasons? J Psychoactive Drugs 1986
Wilcox JA Psychoactive properties of methysergide J Psychoactive Drugs 1987
Lehmann J, DeSouza EB, Cu... Regional distribution to recovery of 5-HT levels after administration ... Ann N Y Acad Sci 1992
Gouzoulis E, von Bardeleb... Neuroendocrine and cardiovascular effects of MDE in healthy volunteers Neuropsychopharmacol... 1993
Newmeyer JA X at the crossroads J Psychoactive Drugs 1993
Strassman RJ, Qualls CR Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendoc... Arch Gen Psychiatry 1994
Millman RB, Beeder AB The new psychedelic culture: LSD, ecstasy, 'rave' parties and the Grat... Psychiatric Annals 1994
Aulakh CS, Mazzola-Pomiet... Role of various 5-HT receptor subtypes in mediating neuroendocrine eff... J Pharmacol Exp Ther 1994
Cornelius MD, Taylor PM, ... Prenatal tobacco and marijuana use among adolescents: effects on offsp... Pediatrics 1995
House RV, Thomas PT, Bhar... Selective modulation of immune function resulting from in vitro exposu... Toxicology 1995
Wright JD, Pearl L Knowledge and experience of young people regarding drug misuse, 1969-9... BMJ 1995
Seymour HR, Gilman D, Qui... Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged e... Diabet Med 1996
Buttar HS, Moffatt JH, Fo... Developmental toxicity of 4-substituted amphetamines in mice Reprod Toxicol 1996
Nakahara Y, Kikura R, Tak... Detection of LSD and metabolite in rat hair and human hair J Anal Toxicol 1996
Callaway JC, Raymon LP, H... Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human ... J Anal Toxicol 1996
Nakahara Y, Kikura R Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethampheta... Biol Pharm Bull 1997
Kintz P, Cirimele V Interlaboratory comparison of quantitative determination of amphetamin... Forensic Sci Int 1997
Kikura R, Nakahara Y, Mie... Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxyme... Forensic Sci Int 1997
Grob CS, Poland RE. MDMA Substance Abuse: A C... 1997
Plessinger MA Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... Obstet Gynecol Clin ... 1998
Moeller MR, Steinmeyer S,... Determination of drugs of abuse in blood J Chromatogr B Biome... 1998
Clement BA, Goff CM, Forb... Toxic amines and alkaloids from Acacia rigidula Phytochemistry 1998
Abrahart D A Critical Review of Theories and Research Concerning Lysergic Acid Di... Masters Thesis 1998
Bertram M, Egelhoff T, Sc... Toxic leukencephalopathy following 'ecstasy' ingestion J Neurol 1999
McCann UD, Eligulashvili ... Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... Psychopharmacology (... 1999
Morgan MJ Ecstasy (MDMA): a review of its possible persistent psychological effe... Psychopharmacology (... 2000
Berman RM, Cappiello A, A... Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000
Nicotra AS, Parvez H Nitric Oxide and Neuronal and Pancreatic Beta Cell Death Toxicology 2000
Gorman EM, Carroll RT Substance abuse and HIV: considerations with regard to methamphetamine... J Assoc Nurses AIDS ... 2000
Rothman RB, Partilla JS, ... Neurochemical neutralization of methamphetamine with high-affinity non... Synapse 2000
Gross ST Detecting psychoactive drugs in the developmental stages of mushrooms J Forensic Sci 2000
Takayama H, Aimi N, Sakai... Chemical studies on the analgesic indole alkaloids from the traditiona... Yakugaku Zasshi 2000
Pacifici R, Zuccaro P, Lo... Acute effects of 3,4-methylenedioxymethamphetamine alone and in combin... J Pharmacol Exp Ther 2001
Zakzanis K, Young DA Executive function in abstinent MDMA ('ecstasy') users Medical Science Moni... 2001
Campo JV, McNabb J, Perel... Kava-induced fulminant hepatic failure J Am Acad Child Adol... 2002
Moeller MR, Kraemer T Drugs of abuse monitoring in blood for control of driving under the in... Ther Drug Monit 2002
Gerra G, Zaimovic A, Moi ... Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopam... Behav Brain Res 2002
Brecht ML, von Mayrhauser... Differences between ecstasy-using and non-using methamphetamine users J Psychoactive Drugs 2002
Passie T, Seifert J, Schn... The pharmacology of psilocybin Addict Biol 2002
Williams MT, Morford LL, ... Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequent... Brain Res 2003
Romanelli F, Smith KM, Po... Use of club drugs by HIV-seropositive and HIV-seronegative gay and bis... Top HIV Med 2003
Yacoubian GS Correlates of ecstasy use among students surveyed through the 1997 Col... J Drug Educ 2003
Schenk S, Gittings D, Joh... Development, maintenance and temporal pattern of self-administration m... Psychopharmacology (... 2003
Engelsman EL Cannabis Control: the model of the WHO tobacco control treaty International Journa... 2003
Gerra G, Bassignana S, Za... Hypothalamic-pituitary-adrenal axis responses to stress in subjects wi... Psychiatry Res 2003
Jacobsen LK, Mencl WE, Pu... Preliminary evidence of hippocampal dysfunction in adolescent MDMA ('e... Psychopharmacology (... 2003
Pacifici R, Pichini S, Zu... Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Huma... J Pharmacol Exp Ther 2004
Halpern JH Hallucinogens and dissociative agents naturally growing in the United ... Pharmacol Ther 2004
Parks KA, Kennedy CL Club Drugs: Reasons for and Consequences of Use J Psychoactive Drugs 2004
Narendran R, Frankle WG, ... Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... Am J Psychiatry 2005
Budayova-Spano M, Dauverg... A methodology and an instrument for the temperature-controlled optimiz... Acta Crystallogr D B... 2007
Silins E, Copeland J, Dil... Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use o... Aust N Z J Psychiatr... 2007
Sessa B, Nutt DJ MDMA, politics and medical research: have we thrown the baby out with ... J Psychopharmacol 2007
Tekbas OF, Ogur R, Korkma... Melatonin as an antibiotic: new insights into the actions of this ubiq... J Pineal Res 2008
Students T Validation of a Gas Chromatography Method for Analysis of Medicinal-Qu... erowid 2008
Lucas PG Regulating compassion: an overview of Canada's federal medical cannabi... Harm Reduct J 2008
Neukamm MA, Mürdter TE, W... Quantitative determination of the active ’Spice’ ingredient JWH-018 in...   2008
Lipton JW, Tolod EG, Thom... 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival o... Neuropharmacology 2008
Lidder S, Dargan P, Sexto... Cardiovascular toxicity associated with recreational use of diphenylpr... J Med Toxicol 2008
Sessa B Is it time to revisit the role of psychedelic drugs in enhancing human... J Psychopharmacol 2008
Carter C Making residential cannabis growing operations actionable: a critical ... Int J Drug Policy 2009
Vogels N, Brunt TM, Rigte... Content of ecstasy in the Netherlands: 1993-2008 Addiction 2009
Baggott MJ, Erowid E, Ero... Use patterns and self-reported effects of Salvia divinorum: An interne... Drug Alcohol Depend 2010
Wohlfarth A, Weinmann W Bioanalysis of new designer drugs   2010
McElrath K, O'Neill C Experiences with mephedrone pre- and post-legislative controls: Percep... Int J Drug Policy 2011
Durham M Ivory wave: the next mephedrone? Emerg Med J 2011
Corazza O, Schifano F, Fa... Designer Drugs on the Internet: a Phenomenon Out-of-Control? The Emerg... Curr Clin Pharmacol 2011
Antonowicz JL, Metzger AK... Paranoid psychosis induced by consumption of methylenedioxypyrovaleron... Gen Hosp Psychiatry 2011
Rodgers J, Buchanan T, He... 'Ecstasy use, by itself, does not result in residual neurotoxicity'- a... Addiction 2011
Spiller HA, Ryan ML, West... Clinical experience with and analytical confirmation of 'bath salts' a... Clin Toxicol (Phila) 2011
Casselman I, Heinrich M Novel Use Patterns of Salvia divinorum: Unobtrusive Observation using ... Journal of Ethnophar... 2011
Ward J, Rhyee S, Plansky ... Methoxetamine: a novel ketamine analog and growing health-care concern Clin Toxicol (Phila) 2011
Olives TD, Orozco BS, Ste... Bath salts: the ivory wave of trouble West J Emerg Med 2012
Caldeira KM, O'Grady KE, ... Marijuana use trajectories during the post-college transition: Health ... Drug Alcohol Depend 2012
Corazza O, Schifano F, Si... Phenomenon of new drugs on the Internet: the case of ketamine derivati... Hum Psychopharmacol 2012
Gallagher CT, Assi S, Sta... 5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal ... Hum Psychopharmacol 2012
Prosser JM, Nelson LS The Toxicology of Bath Salts: A Review of Synthetic Cathinones J Med Toxicol 2012
Toole KE, Fu S, Shimmon R... Color Tests for the Preliminary Identification of Methcathinone and An... Microgram 2012
Baumann MH, Partilla JS, ... Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... Neuropsychopharmacol... 2013
Johnson LA, Johnson RL, P... Current 'Legal Highs' J Emerg Med 2013
Daniulaityte R, Carlson R... I just wanted to tell you that loperamide WILL WORK: a web-based study... Drug Alcohol Depend 2013
Chary M, Genes N, McKenzi... Leveraging social networks for toxicovigilance J Med Toxicol 2013
Patton AL, Seely KA, Pull... Quantitative Measurement of Acetyl Fentanyl and Acetyl Norfentanyl in ... Anal Chem 2014
Oram M Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments ... J Hist Med Allied Sc... 2014
Appendino G, Minassi A, T... Recreational drug discovery: natural products as lead structures for t... Natural Products Rep... 2014
Helander A, Bäckberg M, B... MT-45, a new psychoactive substance associated with hearing loss and u... Clin Toxicol (Phila) 2014
Katselou M, Papoutsis I, ... AH-7921: the list of new psychoactive opioids is expanded Forensic Toxicol 2015
Stogner JM Predictions instead of panics: the framework and utility of systematic... Am J Drug Alcohol Ab... 2015

Page 1 of 2   /   117 Entries Returned
2 next